Back

dr. H.M. van Santen

dr. H.M. van Santen

Associate Professor - medical
dr. H.M. van Santen
  • Endocrinology patient care

Biography

Biography

Dr. HM van Santen moved her career in 2013 to Utrecht to support the Máxima initiative and to coordinate the endocrine care for children with cancer in the Princess Máxima Center. 

She has co-authored 59 publications on the endocrine effects of childhood cancer treatment, of which 32 as first or last author.

She is an associate professor and PI in the research program of Child Health, WKZ, UMCU and co-PI in the Máxima Center for Pediatric Oncology.

Her research program focuses on the endocrine and metabolic effects of children with craniopharyngioma, the acute and late effects of childhood cancer treatment on the endocrine system, and on pediatric thyroid cancer. The overall aim of her work is to preserve an intact endocrine system in children with neoplasms enabling normal growth and development into adulthood.

She is chair of the MC4 group Craniopharyngioma in the Máxima Center for Pediatric Oncology, chair of the Late Effects of Childhood Cancer International Guideline Harmonization Groups (IGHG) for thyroid and hypothalamic-pituitary disorders, and member of the IGHG working groups for male and female gonadal toxicity and preservation of fertility and metabolic syndrome. She is chair of the Dutch and the European Guideline for Thyroid cancer in children and the coordinator of the NFU/ ENDO-ERN expertise center Thyroid Tumors in Utrecht. She is member of the SIOP craniopharyngioma working group and the SIOP low grade glioma working group, the national consortium for Late effects of treatment for childhood thyroid carcinoma, the consortium of the Dexadagen-2 study, the Dutch Growth Hormone Advisory board and has a consultative function for the “Cyberpoli” for thyroid diseases and craniopharyngioma.

Side Activities

2020             co-PI Prinses Maxima Center for Pediatric Oncology Utrecht

2019             BKO qualification UMCU

2019             Chair of the European Task Force for Recommendations of Treatment of Thyroid nodules and Carcinoma in Childhood

2016 – now  Deputy educator ( plaatsvervangend opleider) of the clinical fellow pediatric endocrinology in the Wilhelmina Children’s Hospital, UMCU

2018 - now   member of working group supportive care Princess Maxima Center

2017 - now   member of fertility working group Princess Maxima Center

2016 - now   Co-chair of the IGHG for surveillance of hypothalamic-pituitary disorders in Childhood Cancer Survivors

2016 - now   Participant/ member of the working group of the IGHG working group for  preservation of fertility in male childhood cancer survivors (in progress)

2016 – now  Participant / working group lead of the IGHG working group for preservation of fertility in female childhood cancer survivors (in progress)

2016 - now   Participant/ member of the working group of the IGHG recommendation for surveillance of the metabolic syndrome in childhood cancer survivors (in progress)

2016 - now   Co-chair of the Dutch Guideline for Treatment of Thyroid nodules and cancer in children (in progress)

2016 - now   Participant of  the SIOP supportive care group

2016 - now   Participant of the SIOP low grade glioma working group

2016 - now   Participant of the national consortium for Late effects of treatment for childhood thyroid carcinoma ( PI T Links, UMCG)

2016 - now   Participant of the consortium of the Dexadagen-2 study

2015 - now   Participant of the Dutch Growth Hormone Advisory board (SEK)

2015 - now   Consultative function for the “Cyberpoli” for thyroid diseases and craniopharyngioma(www.cyberpoli.nl)

 2015 – now    Participant of the SKION LATER Recommendations for screening Childhood Cancer Survivors https://www.skion.nl/workspace/uploads/vertaling-richtlijn-LATER-versie-final-okt-2014_2.pdf

 

Fellowship and Awards

2019                KIKA project: THYRO-Dynamics Study (Prospective study on thyroid function during treatment with chemotherapy in 600 children)

2019                Princess Maxima Grant; research grant for 4-year PhD student: “Building an organoid model for craniopharyngioma”

2009-2011      Fellowship kinderendocrinologie in het Emma Kinderziekenhuis AMC

Research Output (92)

Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma

van Iersel Laura, van Santen Hanneke M, Potter Brian, Li Zhenghong, Conklin Heather M, Zhang Hui, Chemaitilly Wassim, Merchant Thomas E 1 dec 2020, In: Pediatric Blood & Cancer. 67

Safety of GH after treatment for childhood cancer

van Santen Hanneke M dec 2020, In: European Journal of Endocrinology. 183 , p. C15-C18

Reproductive Complications in Childhood Cancer Survivors

van Santen Hanneke M, van de Wetering Marianne D, Bos Annelies M E, Vd Heuvel-Eibrink Marry M, van der Pal Helena J, Wallace William Hamish dec 2020, In: The pediatric clinics of North America. 67 , p. 1187-1202 16 p.

Endocrine Health in Childhood Cancer Survivors

van Santen Hanneke M, Chemaitilly Wassim, Meacham Lillian R, Tonorezos Emily S, Mostoufi-Moab Sogol dec 2020, In: The pediatric clinics of North America. 67 , p. 1171-1186 16 p.

Thyroid dysfunction during treatment with systemic antineoplastic therapy for childhood cancer (Protocol)

Lebbink Chantal, Lentjes Eef, Tissing Wim, van den Heuvel-Eibrink M.M., van Santen HM, van Dalen Elvira C dec 2020, In: Cochrane Database of Systematic Reviews . p. 1-9 9 p.

Onco-Fertility Care for Newly Diagnosed Girls With Cancer in a National Pediatric Oncology Setting, The First Experiences From the Princess Maxima Center, The Pearl Study

Van der Perk M. E. M., Van der Kooi A. -L., Van de Wetering M. D., Ijgosse I. M., Van Dulmen-Den Broeder E., Broer S. L., Veening M. A., Klijn A. J., Versluys A. B., Arends B., Ophuis R. J. A. Oude, Van Santen H. M., Van der Steeg A. F. W., Van den Heuvel-Eibrink M. M., Bos A. M. E. dec 2020, In: Pediatric Blood & Cancer. 67 , p. S30-S31

Visual functions in children with craniopharyngioma at diagnosis:A systematic review

Nuijts Myrthe A, Veldhuis Nienke, Stegeman Inge, van Santen Hanneke M, Porro Giorgio L, Imhof Saskia M, Schouten-van Meeteren Antoinette Y N 1 okt 2020, In: PLoS ONE. 15

New national recommendations for the treatment of pediatric differentiated thyroid carcinoma in the Netherlands

Lebbink C. A., Dekker B. L., Bocca G., Braat A. J.A.T., Derikx J. P.M., Dierselhuis M. P., de Keizer B., Kruijff S., Kwast A. B.G., van Nederveen F. H., Nieveen van Dijkum E. J.M., Nievelstein R. A.J., Peeters R. P., Terwisscha van Scheltinga C. E.J., Tissing W. J.E., van der Tuin K., Vriens M. R., Zsiros J., van Trotsenburg A. S.P., Links T. P., van Santen H. M. okt 2020, In: European Journal of Endocrinology. 183 , p. P11-P18

Clinical considerations for the treatment of secondary differentiated thyroid carcinoma in childhood cancer survivors

van Santen Hanneke M., Alexander Erik K., Rivkees Scott A., Frey Eva, Clement Sarah C., Dierselhuis Miranda P., Lebbink Chantal A., Links Thera P., Lorenz Kerstin, Peeters Robin P., Reiners Christoph, Vriens Menno R., Nathan Paul, Schneider Arthur B., Verburg Frederik 1 sep 2020, In: European Journal of Endocrinology. 183 , p. P1-P10

Experiences with Glucagon-Like Peptide-1 Receptor Agonist in Children with Acquired Hypothalamic Obesity

van Schaik Jiska, Begijn Dominique G A, van Iersel Laura, Vergeer Yvonne, Hoving Eelco W, Peeters Babette, van Santen Hanneke M 11 aug 2020, In: Obesity Facts. 13 , p. 361-370 10 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet